Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
LiVeritas Biosciences
AddedFeb 17, 2024
UpdatedJun 18, 2026
LiVeritas Biosciences

LiVeritas Biosciences

Data analytics firm dedicated to ensuring early success in drug development through truth-telling.

HQ
South San Francisco, CA, US
Founded
2020
Overview
Compare
Fundraising
Employees
Website

LiVeritas Biosciences is a data analytics firm focused on accelerating drug development through integrated mass spectrometry (MS) analysis enhanced by machine learning. The company aims to empower biopharmaceutical companies to meet critical pre-clinical to clinical timelines for new therapeutics targeting human diseases. Their services include state-of-the-art LC-MS instrumentation and comprehensive data analytics to ensure early success in drug development.

LiVeritas Biosciences has made significant strides in streamlining the drug development process, providing valuable insights that enable faster and more informed decision-making. Their innovative approach has positioned them as a key partner for biopharmaceutical companies aiming to bring new therapeutics to market efficiently. Their impact is evident in the accelerated timelines and improved outcomes for drug candidates.

LiVeritas Biosciences - Similar Companies

Revolution Biosciences logo

Revolution Biosciences

Sapient logo

Sapient

sapient.bio

Andson Biotech logo

Andson Biotech

andsonbiotech.com

Omix.ai logo

Omix.ai

BioVeras logo

BioVeras

Bioinformatics logo

Bioinformatics

bioinfoinc.com

BioAnalytics logo

BioAnalytics

Verisim Life logo

Verisim Life

verisimlife.com

Elucidata logo

Elucidata

elucidata.io

Terremoto Biosciences logo

Terremoto Biosciences

terremotobio.com

Livivos logo

Livivos

livivos.com

Amador Bioscience logo

Amador Bioscience

Inductive Bio logo

Inductive Bio

inductive.bio

BioAnalytix logo

BioAnalytix

bioanalytixinc.com

Pluto Biosciences logo

Pluto Biosciences

pluto.bio

LiVeritas Biosciences - Quick Facts

Who are LiVeritas Biosciences' competitors?

Companies similar to LiVeritas Biosciences include Revolution Biosciences, Sapient, Andson Biotech and Omix.ai.

When was LiVeritas Biosciences founded?

LiVeritas Biosciences was founded in 2020.

Where is LiVeritas Biosciences' headquarters located?

LiVeritas Biosciences' headquarters is located in South San Francisco, CA, US.

How much has LiVeritas Biosciences raised to-date?

As of Feb 1, 2021, LiVeritas Biosciences has raised a total of $50k (USD).

How many employees does LiVeritas Biosciences have?

LiVeritas Biosciences has 12 employees as of Feb 4, 2024.

LiVeritas Biosciences - Classification

Industry
  • Professional Service Companies
Ownership
  • Private
  • Venture Capital
Technology
  • Analytics
  • Machine Learning
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Data Analytics
Tags
  • Biotech
  • Consulting
  • Data
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software